| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 50 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 50 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 50 |
| 3 | CYTARABINE | 47 |
| 4 | METHOTREXATE SODIUM | 35 |
| 5 | METHOTREXATE | 33 |
| 6 | DEXAMETHASONE | 27 |
| 7 | DEXAMETHASONE 1.5 MG | 27 |
| 8 | ETOPOSIDE | 25 |
| 9 | DOXORUBICIN | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IDARUBICIN HYDROCHLORIDE | 3 | 0.0026 |
| 1 | THIOGUANINE | 4 | 0.0019 |
| 2 | TALAZOPARIB | 3 | 0.0016 |
| 3 | MITOXANTRONE HYDROCHLORIDE | 10 | 0.0016 |
| 4 | ANTI-FUNGAL MICONAZOLE ATHLETES FOOT SPRAY TALC FREE | 2 | 0.0015 |
| 5 | JOCK ITCH SPRAY | 2 | 0.0015 |
| 6 | CLEMASTINE FUMARATE | 2 | 0.0014 |
| 7 | QUIZARTINIB | 1 | 0.0014 |
| 8 | GEMTUZUMAB OZOGAMICIN | 5 | 0.0014 |
| 9 | PURIXAN | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nucleoside Metabolic Inhibitor [EPC] | 57 |
| 1 | Alkylating Drug [EPC] | 55 |
| 2 | Corticosteroid [EPC] | 54 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 33 |
| 4 | Platinum-based Drug [EPC] | 27 |
| 5 | Topoisomerase Inhibitor [EPC] | 25 |
| 6 | Microtubule Inhibitor [EPC] | 19 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 12 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 11 |
| 9 | Azole Antifungal [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD33-directed Immunoconjugate [EPC] | 5 | 0.0014 |
| 1 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 2 | Topoisomerase Inhibitor [EPC] | 25 | 0.0003 |
| 3 | CD19-directed Chimeric Antigen Receptor [EPC] | 3 | 0.0003 |
| 4 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 5 | Histone Deacetylase Inhibitor [EPC] | 1 | 0.0003 |
| 6 | Alkylating Drug [EPC] | 55 | 0.0002 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 57 | 0.0002 |
| 8 | Anticholinergic [EPC] | 3 | 0.0002 |
| 9 | Rifamycin Antibacterial [EPC] | 5 | 0.0001 |